PROFUSA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
PROFUSA, INC. (PFSA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $200.00 thousand for the 12-month period ending 2025-12-31, per its S-1/A filed 2026-05-01.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2026-05-01
- PROFUSA, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2025-12-31 was $100.00K.
- PROFUSA, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2025-09-30 was $100.00K, a 0.00% change year-over-year.
- PROFUSA, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2024-12-31 was $0.00.
- PROFUSA, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2024-09-30 was $100.00K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month |
|---|---|---|---|---|
| 2025-12-31 | $100.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-05-01 | $200.00K derived: sum of 2 quarters · filed 2026-05-01 | $200.00K S-1/A · filed 2026-05-01 | |
| 2025-09-30 | $100.00K 10-Q · filed 2025-11-19 | $100.00K 10-Q · filed 2025-11-19 | ||
| 2024-12-31 | $0.00 derived: S-1/A 12 month − 10-Q 9 month · filed 2026-05-01 | $100.00K derived: sum of 2 quarters · filed 2026-05-01 | $100.00K S-1/A · filed 2026-05-01 | |
| 2024-09-30 | $100.00K 10-Q · filed 2025-11-19 | $100.00K 10-Q · filed 2025-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |